Skip to content

Clinical trials

Terminated Lymphoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Status: Terminated Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20061
20091
20101
20172
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Biomea Fusion Inc.1
Celgene1
CytomX Therapeutics1
Kiadis Pharma1
Novartis Pharmaceuticals1
Radboud University Medical Center1
Sanofi1
Therapeutic Advances in Childhood Leukemia Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma11
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid2
Lymphoma, Follicular2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2
Myelodysplastic Syndromes2
Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.